Suppr超能文献

红细胞输注对非脓毒症危重症患者的影响:一项倾向评分匹配研究。

Effects of red blood cell transfusions given to non-septic critically ill patients: a propensity score matched study.

机构信息

Department of Clinical Sciences, Medical Faculty, Lund University, Lund, Sweden.

Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.

出版信息

Anaesthesiol Intensive Ther. 2021;53(5):390-397. doi: 10.5114/ait.2021.111739.

Abstract

INTRODUCTION

Previous studies have demonstrated that low-grade red blood cell transfusions (RBC) given to septic patients are harmful. The objectives of the present study were to compare mortality and morbidity in non-septic critically ill patients who were given low-grade RBC transfusions at haemoglobin level > 70 γ L-1 with patients without RBC-transfusions any of the first 5 days in intensive care.

MATERIAL AND METHODS

Adult patients admitted to a general intensive care unit between 2007 and 2018 at a university hospital were eligible for inclusion. Patients who received > 2 units RBC transfusion per day during the first 5 days after admisasion, with pre-transfusion haemoglobin level < 70 γ L-1 or with severe sepsis or septic shock, were excluded.

RESULTS

In total, 9491 admissions were recorded during the study period. Propensity score matching resulted in 2 well matched groups with 674 unique patients in each. Median pre-transfusion haemoglobin was 98 γ L-1 (interquartile range 91-107 γ L-1). Mortality was higher in the RBC group with an absolute risk increase for death at 180 days of 5.9% (95% CI: 3.6-8.3; P < 0.001). Low-grade RBC-transfusion was also associated with renal, circulatory, and respiratory failure as well as a higher SOFA-max score. Sensitivity analyses suggested that disease trajectories during the exposure time did not significantly differ between the groups.

CONCLUSIONS

Low-grade RBC-transfusions given to non-septic critically ill patients without significant anaemia were associated with increased mortality, increased kidney, circulatory, and respiratory failure, as well as higher SOFA-max score.

摘要

介绍

先前的研究表明,给脓毒症患者输注低剂量红细胞(RBC)是有害的。本研究的目的是比较血红蛋白水平> 70 γ L-1的非脓毒症危重症患者在第 1 天至第 5 天内输注低剂量 RBC 与无任何 RBC 输注的患者的死亡率和发病率在重症监护室。

材料和方法

符合条件的患者为 2007 年至 2018 年期间在一家大学医院普通重症监护病房住院的成年患者。排除了在入院后第 1 天内每天接受> 2 单位 RBC 输注、输血前血红蛋白水平< 70 γ L-1或患有严重脓毒症或脓毒性休克的患者。

结果

在研究期间共记录了 9491 次入院。通过倾向评分匹配得到了 2 个匹配良好的组,每组各有 674 例独特的患者。输血前血红蛋白中位数为 98 γ L-1(四分位距 91-107 γ L-1)。RBC 组的死亡率更高,180 天死亡率的绝对风险增加 5.9%(95%CI:3.6-8.3;P < 0.001)。低剂量 RBC 输血也与肾功能衰竭、循环衰竭和呼吸衰竭以及更高的 SOFA-max 评分相关。敏感性分析表明,两组在暴露期间的疾病轨迹没有显著差异。

结论

给无明显贫血的非脓毒症危重症患者输注低剂量 RBC 与死亡率增加、肾功能衰竭、循环衰竭和呼吸衰竭以及更高的 SOFA-max 评分相关。

相似文献

8
Anemia and blood transfusion in critically ill patients.危重症患者的贫血与输血
JAMA. 2002 Sep 25;288(12):1499-507. doi: 10.1001/jama.288.12.1499.

引用本文的文献

1
Announcing new members of the Advisory Editorial Board.宣布顾问编辑委员会的新成员。
Anaesthesiol Intensive Ther. 2021;53(4):289. doi: 10.5114/ait.2021.110564.

本文引用的文献

5
Mechanisms of red blood cell transfusion-related immunomodulation.红细胞输血相关免疫调节机制。
Transfusion. 2018 Mar;58(3):804-815. doi: 10.1111/trf.14488. Epub 2018 Jan 30.
6
Indications for and Adverse Effects of Red-Cell Transfusion.红细胞输注的适应证及不良反应
N Engl J Med. 2017 Sep 28;377(13):1261-1272. doi: 10.1056/NEJMra1612789.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验